Joseph Beranek - Columbia Seligman Executive
| STK Etf | USD 32.68 0.21 0.64% |
| Age | 55 |
| Tenure | 5 years |
| Phone | 800 225 2365 |
| Web | https://www.columbiathreadneedleus.com/investment-products/Closed-End-Funds/Columbia-Seligman-Premium-Technology-Growth-Fund/-/details?cusip=19842X109 |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Albert Laskaj | Cohen And Steers | 43 | |
| Susan Sutherland | Eaton Vance Tax | 64 | |
| Thomas Faust | Eaton Vance Enhanced | 63 | |
| Helen Peters | Eaton Vance Tax Managed | 73 | |
| Christopher Accettella | BlackRock Health Sciences | N/A | |
| Charles Park | Blackrock Enhanced Equity | 54 | |
| Dr MS | Tekla Healthcare Investors | 72 | |
| Adrian CFA | BlackRock Limited Duration | N/A | |
| Kyle CFA | BlackRock Health Sciences | N/A | |
| Thomas CFA | BlackRock Health Sciences | N/A | |
| James CFA | BlackRock Limited Duration | 49 | |
| Michael Holland | Reaves Utility If | 75 | |
| Charles Park | BlackRock Utility Infrastructur | 58 | |
| William Ogden | Pimco Corporate Income | 75 | |
| Thomas Kent | Tekla Healthcare Investors | 67 | |
| Thomas Faust | Eaton Vance Tax Managed | 63 | |
| Michael Castellano | Blackrock Enhanced Equity | 75 | |
| Laura Woodward | Tekla Healthcare Investors | 51 | |
| Robert Hubbard | BlackRock Limited Duration | 63 | |
| Frank Fabozzi | Blackrock Enhanced Equity | 73 | |
| Jay Fife | BlackRock Health Sciences | 51 | |
Columbia Seligman Premium Money Managers
| Michael DeFao, Vice President Assistant Secretary | ||
| Joseph Beranek, Principal Financial Officer, Chief Accounting Officer (Principal Accounting Officer), Treasurer | ||
| Sandra Yeager, Independent Director | ||
| Colin Moore, Senior Vice President | ||
| Paul Goucher, Senior Vice President, Chief Legal Officer, Assistant Secretary | ||
| Catherine Paglia, Independent Chairman of the Board | ||
| Minor Shaw, Independent Director | ||
| Daniel Beckman, Senior Vice President | ||
| Amy Johnson, Vice President | ||
| Christopher Petersen, President, Principal Executive Officer, Director | ||
| Brian Gallagher, Independent Director | ||
| Michael Clarke, Chief Financial Officer (Principal Financial Officer), Senior Vice President | ||
| Thomas McGuire, Senior Vice President, Chief Compliance Officer | ||
| Patricia Flynn, Independent Director | ||
| William Truscott, Senior Vice President Director | ||
| Lyn KephartStrong, Vice President | ||
| Anthony Santomero, Independent Director | ||
| Pamela Carlton, Independent Director | ||
| Ryan Larrenaga, Senior Vice President, Secretary, Chief Legal Officer | ||
| George Batejan, Independent Director | ||
| Kathleen Blatz, Independent Director |
Columbia Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Columbia Seligman a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 15.92 M | ||||
| Shares Owned By Institutions | 12.78 % | ||||
| Number Of Shares Shorted | 23.32 K | ||||
| Price To Earning | 2.26 X | ||||
| Short Ratio | 0.63 X | ||||
| Earnings Per Share | 10.70 X | ||||
| Number Of Employees | 17 | ||||
| Beta | 1.16 | ||||
| Market Capitalization | 465.93 M | ||||
| Total Asset | 740 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Columbia Etf
Columbia Seligman financial ratios help investors to determine whether Columbia Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Columbia with respect to the benefits of owning Columbia Seligman security.